Studying hepcidin and related pathways in osteoblasts using a mouse model with insulin receptor substrate 1‑loss of function

  • Authors:
    • Jia Liu
    • Ling Qian
    • Linna Guo
    • Yunzhi Feng
  • View Affiliations

  • Published online on: October 25, 2017     https://doi.org/10.3892/mmr.2017.7876
  • Pages: 350-357
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hepcidin is one of the most important proteins in iron metabolism. In the present study, its role in iron metabolism and the associated signaling pathways involved was investigated in a mouse model with insulin receptor substrate 1‑loss of function (IRS‑/‑), and osteoblasts in the iron overload condition. Protein expression levels of hepcidin, interleukin 6 (IL‑6), bone morphogenetic protein receptor 1α and ferritin demonstrated a significant increase in the liver of the IRS‑/‑ mice compared with the IRS+/‑ and IRS+/+ mice. Hepcidin levels in the jaw bone were also increased in the IRS‑/‑ mice (although not significantly). Furthermore, mRNA expression levels of bone morphogenetic protein 6 (BMP6) and ferroportin (FPN) were significantly increased in the liver of the IRS‑/‑ mice compared with the other two models, but no significant differences were observed in the transferrin receptor mRNA expression levels. Additionally, the mRNA expression of hepcidin, FPN and IL‑6 was upregulated in osteoblasts after ferric ammonium citrate exposure, while the mRNA expression of BMP6 was inhibited. Collectively, the results of the present study indicated that hepcidin is involved in iron metabolism in IRS‑1‑/‑ mice via the signaling pathways involving BMP6 and IL‑6. Furthermore, hepcidin is also involved in iron metabolism in osteoblasts under iron overload conditions. Therefore, hepcidin and its associated signaling pathway proteins may represent potential targets for the treatment of conditions associated with iron overload.
View Figures
View References

Related Articles

Journal Cover

January-2018
Volume 17 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu J, Qian L, Guo L and Feng Y: Studying hepcidin and related pathways in osteoblasts using a mouse model with insulin receptor substrate 1‑loss of function. Mol Med Rep 17: 350-357, 2018
APA
Liu, J., Qian, L., Guo, L., & Feng, Y. (2018). Studying hepcidin and related pathways in osteoblasts using a mouse model with insulin receptor substrate 1‑loss of function. Molecular Medicine Reports, 17, 350-357. https://doi.org/10.3892/mmr.2017.7876
MLA
Liu, J., Qian, L., Guo, L., Feng, Y."Studying hepcidin and related pathways in osteoblasts using a mouse model with insulin receptor substrate 1‑loss of function". Molecular Medicine Reports 17.1 (2018): 350-357.
Chicago
Liu, J., Qian, L., Guo, L., Feng, Y."Studying hepcidin and related pathways in osteoblasts using a mouse model with insulin receptor substrate 1‑loss of function". Molecular Medicine Reports 17, no. 1 (2018): 350-357. https://doi.org/10.3892/mmr.2017.7876